254 related articles for article (PubMed ID: 24440991)
1. Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.
Fujihashi K; Sato S; Kiyono H
Exp Gerontol; 2014 Jun; 54():21-6. PubMed ID: 24440991
[TBL] [Abstract][Full Text] [Related]
2. Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells.
Tsuruhara A; Aso K; Tokuhara D; Ohori J; Kawabata M; Kurono Y; McGhee JR; Fujihashi K
Int Immunol; 2017 Jan; 29(1):5-10. PubMed ID: 28391291
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
4. CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
Tateishi K; Fujihashi K; Yamamoto N; Hasegawa H; Ainai A; Sato K; Iho S; Yamamoto S; Maeyama JI; Odagiri T; Asanuma H
Vaccine; 2019 Aug; 37(36):5382-5389. PubMed ID: 31345642
[TBL] [Abstract][Full Text] [Related]
5. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
Vintiñi E; Villena J; Alvarez S; Medina M
Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
[TBL] [Abstract][Full Text] [Related]
6. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Boyaka PN
J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
[TBL] [Abstract][Full Text] [Related]
7. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K
J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514
[TBL] [Abstract][Full Text] [Related]
8. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage.
Sun K; Johansen FE; Eckmann L; Metzger DW
J Immunol; 2004 Oct; 173(7):4576-81. PubMed ID: 15383591
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
[TBL] [Abstract][Full Text] [Related]
11. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
[TBL] [Abstract][Full Text] [Related]
14. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
15. Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review.
Sato S; Kiyono H; Fujihashi K
Gerontology; 2015; 61(4):336-42. PubMed ID: 25531743
[TBL] [Abstract][Full Text] [Related]
16. Elicitation of mucosal immunity by proteins of Streptococcus pneumoniae.
Briles DE; Miyaji E; Fukuyama Y; Ferreira DM; Fujihashi K
Adv Otorhinolaryngol; 2011; 72():25-7. PubMed ID: 21865682
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
18. The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines.
Kurono Y
Auris Nasus Larynx; 2022 Feb; 49(1):1-10. PubMed ID: 34304944
[TBL] [Abstract][Full Text] [Related]
19. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.
Chen D; Periwal SB; Larrivee K; Zuleger C; Erickson CA; Endres RL; Payne LG
J Virol; 2001 Sep; 75(17):7956-65. PubMed ID: 11483740
[TBL] [Abstract][Full Text] [Related]
20. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
